Company: BL
Filing Date: 2025-08-05
Form Type: 8-K
Source: 0001666134-25-000029
Chunk: 0

Company: BLACKLINE, INC.
Filing Date: 2025-08-05
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 5, 2025, BlackLine, Inc. (the “ Company”) announced that Therese Tucker, Co-CEO and Founder of BlackLine, will transition from her role as Co-CEO, effective October 1, 2025. As of that date, Ms. Tucker will continue to serve as Founder, while Owen Ryan, currently Co-CEO and Chairman, will continue as sole CEO and Chairman of the Company’s board of directors (“ Board”). In the Founder role, Ms. Tucker will continue as a member of the Company’s executive team and Board.

In connection with the transition of her role, Ms. Tucker’s base salary will decrease to $460,000 and her annual target bonus percentage will be 80% of her base salary. Ms. Tucker’s outstanding equity awards will continue on their present terms and she will continue to be eligible for equity awards. The Company anticipates entering into a new employment agreement with Ms. Tucker, the material terms of which will be disclosed separately when the new employment agreement is executed.

In connection with his transitioning to serving as the Company’s sole CEO, effective October 1, 2025, Mr. Ryan’s base salary will increase to $600,000 and his annual target bonus percentage will remain the same. Mr. Ryan’s outstanding equity awards will continue on their present terms and he will continue to be eligible for equity awards.

The Company also announced that the Board has named David Henshall as Lead Independent Director, replacing Tom Unterman, effective August 1, 2025. Mr. Henshall has served on the Board since 2024 and is a member of the Compensation Committee and Nominating and Corporate Governance Committee of the Board. Mr. Unterman will continue to serve on the Board, and as a member of the Board’s Compensation Committee and Nominating and Corporate Governance Committee.

Item 9.01 Financial Statements and Exhibits.